Revenue (Tables)

12 Months Ended

Dec. 31, 2023

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregated Revenue

The following table presents our disaggregated revenue for the periods presented (in thousands):

	Year Ended December 31,
	2023		2022		2021
Immune Medicine revenue
Service revenue	$	24,959	$	31,777	$	24,482
Collaboration revenue		42,578		66,387		63,651
Total Immune Medicine revenue		67,537		98,164		88,133
MRD revenue
Service revenue		102,739		81,144		56,211
Regulatory milestone revenue		—		6,000		10,000
Total MRD revenue		102,739		87,144		66,211
Total revenue	$	170,276	$	185,308	$	154,344